(19)
(11)
EP 0 178 299 A1
(12)
(43)
Date of publication:
23.04.1986
Bulletin 1986/17
(21)
Application number:
84901535.0
(22)
Date of filing:
21.03.1984
(51)
International Patent Classification (IPC):
A61K
9/
20
( . )
A61K
31/
19
( . )
A61K
9/
22
( . )
(86)
International application number:
PCT/US1984/000431
(87)
International publication number:
WO 1985/004099
(
26.09.1985
Gazette 1985/21)
(84)
Designated Contracting States:
AT BE CH DE FR GB LI LU NL SE
(71)
Applicant:
Key Pharmaceuticals, Inc.
Miami, Florida 33169 (US)
(72)
Inventor:
HSIAO, Charles, H.
Cooper City, FL 33328 (US)
(74)
Representative:
Werner, Hans-Karsten, Dr.
Patentanwälte Von Kreisler-Selting-Werner Postfach 10 22 41
D-50462 Köln
D-50462 Köln (DE)
(54)
SUSTAINED RELEASE ORAL DOSAGE FORM FOR NAPROXYN